(A) Individuals were grouped based on their pre-existing anti-HBs (100 mIU/ml (dark blue). (B) Geometric mean titers of anti-HBs post-booster among individuals with different pre-existing anti-HBs.</p
<p>Booster doses administered to short/long responders and duration of anti-HBs positivity.</p
Hepatitis B vaccination (three-dose series) induces long-term immunity, but it is not uncommon to fi...
<p>Major proportion of HBeAg positive subjects were associated with higher HBV DNA levels compared t...
Percentage of individuals with pre-existing anti-HBs 10 mIU/ml) post-booster.</p
Individuals with insufficient protective anti-HBs (<10 mIU/ml) classified into 3 groups (<1 mIU/ml, ...
<p>Line at GMC. A) The anti-HBs levels in the groups were not significantly different. B) The anti-H...
<p>Each data point represents one student aged 17–23 years, born after the adoption of universal neo...
Evolution of Anti-HBs titers was depicted in the subset of 67 individuals who seroconverted for Anti...
<p>Comparison of anti-HBs antibodies levels in patients positive for both anti-HBc and anti-HBs Ab (...
<p>Decrease in antibody to hepatitis B surface antigen (anti-HBs) by time since vaccination, and pea...
a<p>Anti-HBs level was expressed in geometric mean concentration followed by minimum and maximum val...
BACKGROUND/AIMS: The 'anti-Hbc alone' pattern could sometimes be that of subjects who produced anti-...
<p>Summary of Anti-HBs concentrations for vaccinated participants who have received ≥ 3 doses of HBV...
<p>Table shows number at risk, number of subjects with undetectable HBsAb (HBsAb <10), and the perce...
<p>(A) A box indicates a median and interquartile range, and error bars denote the 10th and 90th per...
<p>Booster doses administered to short/long responders and duration of anti-HBs positivity.</p
Hepatitis B vaccination (three-dose series) induces long-term immunity, but it is not uncommon to fi...
<p>Major proportion of HBeAg positive subjects were associated with higher HBV DNA levels compared t...
Percentage of individuals with pre-existing anti-HBs 10 mIU/ml) post-booster.</p
Individuals with insufficient protective anti-HBs (<10 mIU/ml) classified into 3 groups (<1 mIU/ml, ...
<p>Line at GMC. A) The anti-HBs levels in the groups were not significantly different. B) The anti-H...
<p>Each data point represents one student aged 17–23 years, born after the adoption of universal neo...
Evolution of Anti-HBs titers was depicted in the subset of 67 individuals who seroconverted for Anti...
<p>Comparison of anti-HBs antibodies levels in patients positive for both anti-HBc and anti-HBs Ab (...
<p>Decrease in antibody to hepatitis B surface antigen (anti-HBs) by time since vaccination, and pea...
a<p>Anti-HBs level was expressed in geometric mean concentration followed by minimum and maximum val...
BACKGROUND/AIMS: The 'anti-Hbc alone' pattern could sometimes be that of subjects who produced anti-...
<p>Summary of Anti-HBs concentrations for vaccinated participants who have received ≥ 3 doses of HBV...
<p>Table shows number at risk, number of subjects with undetectable HBsAb (HBsAb <10), and the perce...
<p>(A) A box indicates a median and interquartile range, and error bars denote the 10th and 90th per...
<p>Booster doses administered to short/long responders and duration of anti-HBs positivity.</p
Hepatitis B vaccination (three-dose series) induces long-term immunity, but it is not uncommon to fi...
<p>Major proportion of HBeAg positive subjects were associated with higher HBV DNA levels compared t...